MedPath

Seoul National University Hospital

Seoul National University Hospital logo
🇰🇷South Korea
Ownership
Private
Established
2003-01-01
Employees
501
Market Cap
-
Website
https://www.snubh.org

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

Phase 4
Conditions
Parkinson's Disease
Interventions
First Posted Date
2012-01-24
Last Posted Date
2012-01-24
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
200
Registration Number
NCT01515774
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty

Not Applicable
Completed
Conditions
Avascular Necrosis of Hip
Total Hip Replacement Arthroplasty
Interventions
First Posted Date
2012-01-19
Last Posted Date
2014-01-28
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
75
Registration Number
NCT01512628
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyounggi, Korea, Republic of

Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients

Phase 4
Conditions
Proteinuria
Interventions
Drug: Placebo
First Posted Date
2012-01-19
Last Posted Date
2012-04-10
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
240
Registration Number
NCT01512862
Locations
🇰🇷

SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of

🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors

Phase 3
Completed
Conditions
Gastric Tumor
Helicobacter Pylori
Endoscopic Resection
Metachronous Neoplasms
Interventions
Drug: eradication treatment of Helicobacter pylori infection
First Posted Date
2012-01-16
Last Posted Date
2012-03-14
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
855
Registration Number
NCT01510730
Locations
🇰🇷

Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul, Korea, Republic of

Ultrasound Guided Central Vein Catheterization and Complications

Not Applicable
Completed
Conditions
Brain Tumor
Interventions
Procedure: Catheterization of internal jugular vein
Procedure: Catheterization of subclavian vein
First Posted Date
2012-01-16
Last Posted Date
2018-08-27
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
1484
Registration Number
NCT01510743
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyounggi, Korea, Republic of

Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes

Completed
Conditions
Type 2 Diabetes
First Posted Date
2012-01-12
Last Posted Date
2012-10-10
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
1500
Registration Number
NCT01508481
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

Population Pharmacokinetics and Metabolomics of Theophylline in Preterm Infants

Conditions
Apea of Prematurity
First Posted Date
2012-01-12
Last Posted Date
2012-02-23
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
110
Registration Number
NCT01509248

Human Papillomavirus in Menstrual Blood

Completed
Conditions
Human Papillomavirus
Interventions
Other: Collecting a Pad used at the first menstrual period after enrollment
First Posted Date
2012-01-09
Last Posted Date
2013-03-05
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
19
Registration Number
NCT01506128
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel

Phase 4
Completed
Conditions
Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
Influence of Aspirin on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
Interventions
Drug: Clopidogrel+Aspirin
First Posted Date
2012-01-04
Last Posted Date
2012-06-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
18
Registration Number
NCT01503658
Locations
🇰🇷

Seoul National University Hospital Clinical Trials Center, Seoul, Korea, Republic of

Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis

Phase 1
Completed
Conditions
Liver Cirrhosis
Interventions
Drug: G-colony stimulating factor
Other: Infusion of the mobilized monocyte cells
First Posted Date
2012-01-04
Last Posted Date
2014-12-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
9
Registration Number
NCT01503749
© Copyright 2025. All Rights Reserved by MedPath